INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 230 filers reported holding INARI MED INC in Q2 2022. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,669,811 | +90.4% | 193,728 | +69.2% | 0.00% | 0.0% |
| Q2 2023 | $6,655,983 | -50.1% | 114,482 | -47.0% | 0.00% | 0.0% |
| Q1 2023 | $13,345,411 | +69.6% | 216,155 | +74.6% | 0.00% | 0.0% |
| Q4 2022 | $7,868,092 | -18.1% | 123,790 | -6.4% | 0.00% | 0.0% |
| Q3 2022 | $9,603,000 | +12.0% | 132,189 | +4.9% | 0.00% | 0.0% |
| Q2 2022 | $8,571,000 | -21.7% | 126,066 | +4.4% | 0.00% | 0.0% |
| Q1 2022 | $10,941,000 | +17.7% | 120,707 | +18.5% | 0.00% | 0.0% |
| Q4 2021 | $9,297,000 | +17.0% | 101,868 | +4.0% | 0.00% | 0.0% |
| Q3 2021 | $7,943,000 | -53.8% | 97,950 | -46.9% | 0.00% | -50.0% |
| Q2 2021 | $17,206,000 | +25.0% | 184,461 | +43.4% | 0.00% | 0.0% |
| Q1 2021 | $13,766,000 | +118.6% | 128,648 | +78.3% | 0.00% | +100.0% |
| Q4 2020 | $6,297,000 | +2775.3% | 72,133 | +2176.2% | 0.00% | – |
| Q3 2020 | $219,000 | +138.0% | 3,169 | +66.3% | 0.00% | – |
| Q2 2020 | $92,000 | – | 1,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |